top of page

Laxxon has both an external pipeline and an in-house Advanced Patented Generic pipeline.

All products created with our SPID®-Technology manufacturing approach are patent protected, whether engineered in-house or with an external partner.

Product

2021

2022

2023

2024

2025

LXM.1

Epilepsy

LXM.3

Pain Relief

LXM.2

Diabetes

LXM.5

Parkinson's

LXM.11

Anticoagulant

LXM.16

ADHD

LXM.16

ADHD

External Programs

In-house Programs

Product Registration

Product Launch

Analytical Testing

Clinical Testing

Initial Test Printing

Laxxon - [screen printing (white)].png

Product Pipeline

Learn more about our internal and external pipelines

Wide array of Laxxon's 3D printed tablets

Laxxon has both an external pipeline and an in-house Advanced Patented Generic pipeline.

All products created with our SPID®-Technology manufacturing approach are patent protected, whether engineered in-house or with an external partner.

External Programs

In-house Programs

Initial Test Printing

Analytical Testing

Clinical Testing

Product Registration

Product Launch

bottom of page